Island Kinetics, Inc. (d.b.a. CoValence Laboratories) is recalling 2,542 units of PCA Skin Blemish Control Bar (salicylic acid 2%), an acne cleanser. The recall was initiated because testing found the salicylic acid content is higher than the company's approved specifications, making the drug product superpotent. Consumers who have purchased this product should contact their healthcare provider or pharmacist for guidance regarding any skin irritation or adverse reactions.
The product contains a concentration of salicylic acid that exceeds safety specifications, which may increase the risk of severe skin irritation, redness, or chemical sensitivity beyond what is expected for a standard acne treatment.
Healthcare consultation and refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.